AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05384132 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SRP + Livfresh Dental Gel
Description: SRP at baseline with use of LDG (test dentifrice) for twice daily brushing between study visits. Scaling and root planing is the physical removal of dental plaque, calculus, and bacterial exotoxins embedded onto the root surface of effected teeth with hand instruments and ultrasonic devices. In addition to scaling and root planing, the participants will use LDG as their primary dentrifice (toothpaste) for the next 6 months. They're instructed to use LDG twice daily with toothbrushing for 2 minutes. LDG in previous studies have been reported to be superior to conventional over-the-counter toothpaste in terms of reducing bacterial plaque and gingival inflammation due to its EDTA (ethylenediaminetetraacetic acid) ingredient. EDTA prevents adhesion of bacterial plaque to teeth.
Study NCT05384132 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SRP + standard flouride dentifrice
Description: SRP at baseline with use of standard fluoride dentifrice (control dentifrice) for twice daily brushing between study visits. Scaling and root planing is the physical removal of dental plaque, calculus, and bacterial exotoxins embedded onto the root surface of effected teeth with hand instruments and ultrasonic devices. In addition to scaling and root planing, the participants will use standard fluoride toothpaste (commercial over-the-counter toothpaste) as their primary dentrifice (toothpaste). They're instructed to use standard fluoride toothpaste twice daily with toothbrushing for 2 minutes.
Study NCT05593588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fisetin
Description: 20 mg per kilogram (kg) of body weight supplied in 100 mg capsules and administered orally on days 0, 1, 28, and 29
Study NCT04964674 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Measurement
Description: Take measurements of behavioral performance
Study NCT05539482 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Information Sharing Group
Description: Collaborators are encouraged to collect and share health information to the participants. Shared information should be previewed by researchers.
Study NCT06239558 — intervention group
Intervention type: OTHER
Intervention: Qualitative exploration
Description: Semi-structured Interviews and focus group
Study NCT05288192 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Suprachoroidal triamcinolone acetonide (SCTA) injection
Description: Suprachoroidal injection of 4mg/0.1ml of triamcinolone acetonide.
Study NCT05074914 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: oesophagectomy
Description: removal of oesophagus
Study NCT06407713 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intrinsic foot muscle training
Description: The duration of intervention will be 6 weeks, 3 sessions a week, a total of 18 sessions will be given to the study participants. Each session will last for 30 minutes. Conventional physical therapy will be given to participants along with intrinsic foot muscle training
Study NCT06407713 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hip abductor muscle training
Description: The duration of intervention will be 6 weeks, 3 sessions a week, a total of 18 sessions will be given to the study participants. Each session will last for 30 minutes. Conventional physical therapy will be given to participants along with hip abductor muscle training
Study NCT04881084 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital storytelling group
Description: Participants (intervention- group 1) will watch digital stories, short videos describing the experience of recovering from mental illness created as part of this project. Participants in the control group (group 2) will watch social marketing and/or fundraising campaigns on similar topics and complete a few questionnaires. The following standardized scales will be used: The Level of Familiarity Scale (LOF) (which will be used only before exposure to movies); Toronto Empathy Questionnaire (16 items; internal consistency coefficient .79; test-retest reliability coefficient .73), Compassionate Love Scale (21 items; Cronbach's alpha: .95; item-to-total correlations ranging from .46 to .81), Dispositional Positive Emotions Scale (DPES) (5 items; Cronbach's alpha for the compassion subscale: .80; inter-scale correlations: .44), Self-Stigma of Mental Illness Scale-Short Form (SSMIS-SF) (20 items; Cronbach's alpha: 0.91); Difference and Disdain Scales for Public Stigma (DDSPS) (9 items).
Study NCT04881084 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Social marketing/fundraising group
Description: Participants will be randomly assigned to the social marketing/fundraising group (n = 40 participants; 20 Anglophone and 20 Francophone; ages 18-35). Participants will be asked to watch twenty-six social marketing/fundraising videos which will be assessed using a between-subjects design.
Study NCT05593588 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Looks exactly like the study drug, but it contains no active ingredient. Administered orally on days 0, 1, 28 and 29
Study NCT06302816 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TUPLER exercises
Description: will be conducting tupler exercises, exercises that are designed to target core muscles in order to improve posture, regain core strength and reducing discomfort.~Each exercise will be repeated 10reps for 3 times on 3 days a week for 8 weeks.
Study NCT06302816 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SCOOP EXERCISES
Description: will be required to complete scoop exercises basically deals with Pilates which is deep core and hip strengthening and stability through breathing patterns with the utilization of transversus abdominis muscle majorly. In each exercise participant will be asked to hold pelvic floor muscles for 8sec, then relax the muscles and count to 10, repeat I for 10 times each day for 3 days a week for 8weeks. Basic commands about the positing, activation and engagement of core along with breathing control were given to the subjects.
Study NCT06450743 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Lymphocyte Immunophenotyping Test
Description: Absolute enumeration of peripheral blood lymphocyte subpopulations
Study NCT06220084 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance for PD®
Description: The intervention consists of 16 60-min adapted to Greek culture DfPD® classes, which will be performed twice weekly for 8 weeks and instructed by a single researcher, who has the approval to use it for research reasons. The intervention will be delivered both live and online in separate periods for each participant.
Study NCT04921865 — intervention group
Intervention type: DEVICE
Intervention: DPS VA-LCP® Clavicle Plate 2.7 System; DPS VA-LCP® Clavicle Hook Plate 2.7 System
Description: The DPS VA-LCP® Clavicle Plate 2.7 System is indicated for the fixation of clavicle bone fragments. The system consists of three plate types: lateral, shaft, and medial, each available in different sizes and materials (titanium alloy and stainless steel). Each plate is available in left and right.~The DPS VA-LCP® Clavicle Clavicle Hook Plate 2.7 System is indicated or the fixation of lateral clavicle fractures and AC joint dislocations. The Clavicle Hook Plate system consists of three plate types: long, short and button plates.
Study NCT05642338 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: WATS3D
Description: the WATS3D brush samples the esophagus by abresing the tissue. the brush is directed through the workingchanel of endoscope into the oesophagus
Study NCT03012243 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gallbladder aspiration
Description: Percutaneous ultrasound-guided aspiration of bile from the gallbladder. This is performed without leaving a drain in the gallbladder. The aspiration is performed with the intention to relief the pressure in the gallbladder, without drain.
Study NCT03012243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cholecystostomy
Description: Ultrasound-guided insertion of drain in the gallbladder. The drain is left in the gallbladder until clinical assessment and laboratory analyses show that the acute cholecystitis has been successfully treated.
Study NCT06207513 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Suction Circuit Flushing with Chlorhexidine
Description: Patient intubated with an endotracheal tube and on a mechanical ventilator will receive endotracheal suctioning procedure using an open endotracheal suction catheter that is used multiple times during a 12-hour nursing shift. Flushing of the suctioning circuit will be performed with 40 ml of chlorhexidine gluconate 0.2% after every endotracheal suction procedure
Study NCT06207513 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Suction Circuit Flushing with Chlorhexidine
Description: Patient intubated with an endotracheal tube and on a mechanical ventilator will receive endotracheal suctioning procedure using an open endotracheal suction catheter that is used multiple times during a 12-hour nursing shift. Flushing of the suctioning circuit will be performed with 40 ml of chlorhexidine gluconate 0.2% after every endotracheal suction procedure
Study NCT06334861 — intervention group
Intervention type: BIOLOGICAL
Intervention: Herpes Zoster adjuvanted recombinant vaccine
Description: patients will receive two doses of vaccine with an interval between the first and second dose of 2 months
Study NCT05895760 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multi-component physical exercise online intervention
Description: A multicomponent exercise program was implemented consisting of a combined program of endurance, strength, coordination, balance, and flexibility exercises depending on the level of functional capacity.~Three types of physical exercise programs were designed according to the physical performance level of each participant. The first type of exercise program training was performed for frail adults with an SPPB score of 4 to 6, the second was for the pre-frail adults with an SPPB score of 7 to 9 and the third for robust adults with an SPPB of 10 to 12.
Study NCT05079282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-4685
Description: ONO-4685 is administered by IV infusion. The administration of ONO-4685 will be continued until disease progression or unacceptable toxicity is observed
Study NCT04998045 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Screening and brief intervention for substance use
Description: Screening will be done using the WHO Alcohol Smoking and Substance Involvement Screening Test (ASSIST). The brief intervention will be delivered based on ASSIST risk scores: low risk - verbal positive reinforcement and brief advice on harmful consequences of substance use (ii) moderate risk - brief motivational interviewing (BMI) (iii) high risk - BMI and referral to child psychiatry out-patient clinic. The BMI will be delivered in a single session (approximately 15 minutes) using Feedback Listen Options model (15): (i) providing feedback on screening results (ii) exploring pros and cons of substance use, enquiring about importance of change (iii) exploring options for change.
Study NCT05912959 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: photo biostimulation
Description: the intervention is a type of wavelength around 820 nm. this method of treatment is totally safe. yet, it has many therapeutic effects on the cellular level as well as tissue and organ level. during treatment with laser, the patient does not feel any specific sensation.
Study NCT05912959 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: photo biostimulation
Description: the intervention is a type of wavelength around 820 nm. this method of treatment is totally safe. yet, it has many therapeutic effects on the cellular level as well as tissue and organ level. during treatment with laser, the patient does not feel any specific sensation.
Study NCT05526729 — intervention group
Intervention type: OTHER
Intervention: Beovu
Description: Prospective observational study. There is no treatment allocation. Patients prescribed with Beovu for the first time for diabetic macular edema are eligible to enroll into this study.
Study NCT05248737 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: DHA/EPA bioenhanced chicken
Description: Chicken fed on a high DHA/EPA diet
Study NCT05248737 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: 25(OH)D bioenhanced chicken
Description: Chicken fed on a high 25(OH)D diet
Study NCT06083090 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Yogatherapy
Description: The experimental arm will benefit from support by a physiotherapist trained in yoga, in a group for ten weeks with two weekly sessions of approximately 1 hour each. A new yoga program adapted for the axSPA will be implemented.
Study NCT06083090 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: The comparator arm will benefit from support by a physiotherapist, in groups for ten weeks at the rate of two weekly sessions of approximately 1 hour each. An already existing program adapted for the axSPA will be implemented.
Study NCT05247268 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Megestrol Acetate 160 MG Oral Tablet
Description: At a dosage of 160 mg/day
Study NCT05247268 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Medroxyprogesterone Acetate 500 MG
Description: At a dosage of 500 mg/day
Study NCT05247268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triprorelin Acetate
Description: Intramuscular injection of 3.75mg was given 4 weeks apart and the maximum use are 6 courses
Study NCT05247268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5mg
Description: At a dosage of 2.5mg/day and no more than 24 weeks
Study NCT05425836 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard oxygen therapy
Description: nasal cannula
Study NCT06297525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STP938
Description: Small molecule
Study NCT05651503 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics
Description: In our study oral probiotics Lactobacillus salivarius Oral S1 11 (Prodilac Oral, Frezyderm) will be tested in two Experimental groups
Study NCT05651503 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablet
Description: In order to avoid possible bias, probiotics will be compared with placebo lozenges/no probiotic in two Control groups
Study NCT05425836 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HFNC
Description: High flow nasal cannula
Study NCT05561803 — intervention group
Intervention type: RADIATION
Intervention: Photobiomodulation Therapy
Description: Focal low-level laser therapy, Red Laser (wavelength 633 nm to 685 nm), or Infrared Laser Laser (wavelength 780 nm to 830 nm), with a low-intensity laser equipment of 100 mW and a cross-sectional area of the device beam of 0.0434 cm². The parameters are 1 to 3 J per point, with equidistant points of 1.5 to 2 cm, covering the entire length of the open lesion. Therapy is carried out every 48 hours until the total wound healing, regardless of the number of sessions required.
Study NCT04943679 — intervention group
Intervention type: DRUG
Intervention: Anti-PD-1/PD-L1
Description: Intravenous injection for up to 2 years
Study NCT04943679 — intervention group
Intervention type: DRUG
Intervention: PEG-Interferon Alfa
Description: 3 µg/kg every week by subcutaneous injection for up to 2 years
Study NCT05432427 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 64Cu-DOTATATE and 18F-FDG
Description: All participants will get a 64Cu-DOTATATE-PET and 18F-FDG-PET/CT.
Study NCT05231980 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid (ALA)
Description: ALA is sold as a dietary supplement, either by itself or incorporated into a multivitamin product. it also has anti-oxidant effect.
Study NCT05231980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Description: Pentoxifylline is a methylxanthine derivative which acts as a vasodilator by increasing blood flow to tissues, inhibits inflammatory responses, and reduces blood viscosity by impeding platelet aggregation
Study NCT05231980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clomiphene Citrate
Description: is a medication used to treat infertility in women who do not ovulate
Study NCT05231980 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clomiphene Citrate
Description: is a medication used to treat infertility in women who do not ovulate
Study NCT06189794 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rosa damascena oil
Description: Essential oils will used by inhalation
Study NCT06189794 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rosa damascena oil
Description: Essential oils will used by inhalation
Study NCT06189794 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Rosa damascena oil
Description: Essential oils will used by inhalation
Study NCT04033692 — intervention group
Intervention type: DEVICE
Intervention: JuggerKnot Mini Soft Anchor
Description: Patient who have been implanted with one or more JuggerKnot Mini Soft Anchor(s) who have undergone repair, repositioning or reattachment of soft tissues, ligament and tendons to the mandible is require for surgical stabilization of the TMJ articular disc.
Study NCT05303181 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Russian Current
Description: The patient will be placed in sitting position, hip at 90-degree flexion, knee at 60°, the upper body supported by the backrest, cross belt support the trunk and cross belt support the pelvis. The dynamometer rotating axis will be aligned with knee joint axis and the resistance lever arm will place in the distal leg above the malleolus. The angle of the joints adjustment considering the joint's range of motion and the device's user's manual, any movement other than the range of motion determined by the mechanical limit will be not allowed~All electrical induced contraction will last 4 second each, with characteristics of 75 bursts; 4 second time on, 400 μs pulse width and 10 second time off. The greatest electrically induced torque by the quadriceps muscle at the maximum current output from the stimulator will be recorded for each subject to be used in data analysis. The same procedure will be done on the 3rd week and after 6th week.
Study NCT04271527 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cognitive fusion targeted biopsy
Description: A cognitive fusion targeted biopsy
Study NCT04271527 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cognitive fusion targeted biopsy
Description: A cognitive fusion targeted biopsy
Study NCT00748735 — intervention group
Intervention type: PROCEDURE
Intervention: Implantation of a cardiac resynchronization therapy device
Study NCT00748735 — intervention group
Intervention type: PROCEDURE
Intervention: Echocardiography (myocardial deformation imaging)
Study NCT05602909 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Guided biaxial alveolar distraction device
Description: A crestal incision will be done, a surgical guide will be placed to assist the correct position of osteotomy, an Extraosseous alveolar distractor will be placed on the ridge to mark screw sites and then will be removed, A distractor will be stabilized to the basal segment with a monocortical screw.
Study NCT06189105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: miss alice face it you love me serum
Description: Facial serum with niacinamide, plant-based collagen and peptides will be applied by each participant to the treatment site according to randomization protocol every evening
Study NCT06189105 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No treatment (usual skincare rutine)
Description: No treatment (usual skincare rutine)
Study NCT05998096 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine-Based Energy Drink
Description: Caffeine-based energy drink containing 200 mg caffeine
Study NCT05998096 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo void of all active ingredients
Study NCT06206330 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Platelet rich plasma
Description: After application of platelet rich plasma after surgery, the patients have examined for infection, hematoma, pain, recurrence and the time of epithelialization of the wound.
Study NCT05239949 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypopressive exercises
Description: For hypopressive exercises, the patient will be instructed to inhale, then breathe to expand the ribcage, and then exhale completely. Hold the breath out before relaxing core and ribcage.
Study NCT05239949 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic floor exercises
Description: For pelvic floor exercises, the patient is instructed to hold each contraction for 6 seconds.
Study NCT05391984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Activity oriented treatment
Description: 15 patients will be treated with activity oriented therapy. All subjects will receive 20 therapeutic sessions, 5 times a week over the time span of 4 weeks.
Study NCT05391984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structural oriented treatment
Description: 15 patients will be treated with structural oriented therapy. All subjects will receive 20 therapeutic sessions, 5 times a week over the time span of 4 weeks.